Monsanto Roundup Lawsuit

Thursday, March 05, 2009

Atomoxetine (Strattera) for ADHD: risk of psychotic or manic symptoms

The Medicines and Healthcare products Regulatory Agency (MHRA) has published Drug Safety Update for March 2009. One of the drugs reviewed is atomoxetin (Strattera), a SNRI used for the treatment of ADHD. These are the recommendations:

Advice for healthcare professionals:

• At normal doses, atomoxetine can be associated with treatment-emergent psychotic or manic symptoms (eg, hallucinations, delusional thinking, mania, or agitation) in children and adolescents without a history of psychotic illness or mania.

• If such symptoms occur , consideration should be given to a possible causal role of atomoxetine and discontinuation of treatment.

• It remains possible that atomoxetine might exacerbate pre-existing psychotic or manic symptoms.

Fid


Read the new book, The Evidence, However, Is Clear...The Seroxat Scandal

ORDER THE PAPERBACK
'THE EVIDENCE, HOWEVER, IS CLEAR...THE SEROXAT SCANDAL' By Bob Fiddaman

SIGNED COPIES HERE OR UNSIGNED FROM CHIPMUNKA PUBLISHING
Post a Comment